Advertisement

Topics

Companies Related to "A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients" [Most Relevant Company Matches] RSS

08:50 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients" found in our extensive corporate database of over 50,000 company records.

Showing "Safety Pilot Pharmacokinetics Neurocognitive Study Combination With Zidovudine" Companies 1–25 of 2,100+

Relevant

Tyrogenex

Tyrogenex is developing X-82, as a targeted therapeutic for ophthalmological diseases and solid tumors. Preliminary data from a phase 1/2 pilot study show that X-82 is well tolerated and did not exhibit any dose-limiting toxicity during the study.


Cytheris SA

Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation.  These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transp...

Hanmi Pharmaceutical co., Ltd.

Hanmi Pharmaceutical is a Korea-based pharmaceutical company. The Company invests over 20 percent of its sales in R&D and has over 20 programs consisting of the novel long acting biologics including weekly Insulin, weekly to monthly GLP-1, and their combination for diabetes and obesity (collectively referred as Quantum Project), the novel targeted anti-can...


Pilot Pharmaceuticals

Pilot Pharmaceuticals develops novel products to treat CNS disorders with unmet medical need and substantial market size. The Company takes candidate drugs from an early discovery stage into clinical development.Pilot Pharmaceuticals will license its products to pharmaceutical companies, allowing them to complete the clinical development, gain regulatory approval and market the product.Pilot Pharm...

Vascular Dynamics, Inc.

Vascular Dynamics develops catheter-delivered technologies to bring a better quality of life to patients who are resistant to conventional treatments for hypertension. Vascular Dynamics was one of nine companies chosen in 2012 by the FDA to participate in the Early Feasibility Study IDE Pilot Program. The company is conducting open-label, controlled, multi...

Cogtest® inc

Our mission is to deliver effective, reliable and secure assessment and data capture solutions for neurocognitive clinical testing. We began trading via Cognitive Therapeutics(CTx) in 2000 which is now a wholly owned subsidiary of Cogtest® inc. Our clients include leading pharmaceutical companies, CROs and universities

RESprotect GmbH

RESprotect GmbH from Dresden develops drugs that prevent induction of chemoresistance of tumor cells and enhance their chemosensitivity. This concept is worldwide without concurrence. The first drug RP101 significantly extended survival time of pancreas cancer patients in a clinical pilot study.

Flow Sciences, Inc.

Flow Sciences, Inc. (FSI) designs and manufactures safety containment solutions for Research and Development Laboratories, Pilot Facilities, Automation Equipment and Robotics, Manufacturing and Production Plants. Flow Sciences brings improved and customized products to the demanding marketplace ensuring safety and quality solutions. Flow Sciences’ containment products and systems provide many be...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Erimos Technologies, LLC

Erimos has exclusive license for nordihydroguaiaretic acid (NDGA) derivatives from The Johns Hopkins University. We have developed a novel process to extract NDGA from the resin of the leaves of Larrea tridentata, a desert plant indigenous to the southwestern US and Mexico. EM-1421, our lead candidate, is a semi-synthetic derivative of NDGA. It is designed to target specific differences between no...

ZHEJIANG WONDERFUL PHARMA & CHEM CO.

ZHEJIANG WONDERFUL PHARMA & CHEM CO. are always developing new products exclusively to meet our customers needs of antineoplastic bulk drugs both fine chemicals and plant extracts in close collaboration. Follows are our new products: Atorvastatin Ca Stavudine Erdosteine Zoledronic acid or Sodium Zidovudine Moxifloxacin HCl Exemestane Bicalutamide

ADVANCED VIRAL RESEARCH CORP

Advanced Viral Research Corp. (OTC Bulletin Board: ADVR), established in the mid-1980s, and headquartered in Yonkers, New York, is a biopharmaceutical firm dedicated to improving patients' lives by researching, developing, and bringing to market new and effective therapies for many serious diseases and disorders. With the commitment of expert leadership and skilled research scientists, ADVR is ag...

SNBL USA, Ltd.

Headquartered in Everett, WA, SNBL USA, Ltd. offers a unique range of safety assessment services to support the drug development process. Managed and operated by a team world renowned for its wide-ranging NHP experience and expertise, we offer programs ranging from regulatory toxicology to customized study designs and disease models. Our specialized capabi...

BIOCON, INC.

Since 1978 BIOCON has provided highly reliable, custom small animal research services to the region’s leading biomedical scientists. Whether your study involves small animal housing, breeding and colony management, research study applications, safety testing, custom antibody production or fully-compliant Good Laboratory Practices, BIOCON implements our client’s research initiative with dedicat...

Carbylan BioSurgery, Inc.

Carbylan (www.carbylan.com) was founded in 2005 to develop and market medical devices and device/drug combination products based on novel chemically engineered polymer systems incorporating hyaluronic acid, a well-known polysaccharide widely present in the human body. Its initial market focus is therapeutic medical devices and combination products to treat...

Advanced Biomedical Research, Inc

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in the heart of New Jersey's pharmaceutical R&D corridor in Princeton, NJ. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and clinical data ...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

California Neuroscience Research Medical Group, Inc.

California Neuroscience Research (CNR), is located at 4835 Van Nuys Blvd. in the Sherman Oaks Medical Center in Sherman Oaks, California. We perform clinical trial protocols of investigational medications or currently approved medications. These studies, funded primarily by major pharmaceutical sponsors, involve no costs to patients for study-related services. All study protocols are first appro...

Total Safety

Total Safety, a DLJ Merchant Banking Partners portfolio company, based in Houston, Texas, is the world’s leading global provider of integrated safety strategies and the products necessary to support them: on-site safety services, turnaround safety support, gas detection, respiratory services, rescue services, safety training, fire services and engineered ...

International SOS Foundation

Established in 2011, the International SOS Foundation - Ambassadors for Duty of Care - has the goal of improving the safety, security, health and welfare of people working abroad or on remote assignments through the study, understanding and mitigation of potential risks. The escalation of globalization has enabled more individuals to work across borders an...

Ergonomics and Safety

Ergonomics and Safety provides consulting services to companies for prevention of occupational injuries and illnesses. Ergonomics and Safety applies the following ergonomics tools to industrial and office environments for workplace design and development of safety programs

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

ARA Safety

ARA Safety is a world leader in innovative fire and life safety technology. ARA Safety's revolutionary Fire Interruption Technology (FIT) fire knock down tool is saving lives and reducing property loss in cities and towns across North America.

ECA International Corporation

ECA International Corporation, located in Palatine IL, is a fine chemical company that specializes in developing and manufacturing customized pharmaceutical intermediates. We offer gram to kilo level synthesis extending to pilot and commercialization, and process development at gram and pilot scale. Equipped with highly skilled chemists supported by state-of-the-art analytical facility, ECA Intern...

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...


More From BioPortfolio on "A Safety, Pilot Pharmacokinetics and Neurocognitive Study of AS-101 in Combination With Zidovudine in AIDS/ARC Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks